Élisabeth Longchampt

Transcriptomic definition of molecular subgroups of small round cell sarcomas

Sarah Watson, Virginie Perrin, Delphine Guillemot et al. · The Journal of Pathology · 2018 · 330 citations

Medicine, Molecular Biology, Oncology +17

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

Marie Wislez, Martine Antoine, Laurence Baudrin et al. · Lung Cancer · 2009 · 88 citations

Medicine, Oncology, Pathology +14

Accuracy of Cytology vs. Microbiopsy for the Diagnosis of Well-Differentiated Hepatocellular Carcinoma and Macroregenerative Nodule

Élisabeth Longchampt, C Patriarche, Monique Fabrè · Acta Cytologica · 2000 · 76 citations

Medicine, Cell Biology, Pathology +17

Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)

Jacques Cadranel, Audrey Mauguen, M Faller et al. · Journal of Thoracic Oncology · 2012 · 71 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition

Harriet Corvol, Nathalie Rousselet, Kristin Thompson et al. · Journal of Cystic Fibrosis · 2017 · 60 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17